REVOLADE , thrombopoietin receptor agonist

REVOLADE , thrombopoietin receptor agonist revolade Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments revolade REVOLADE 50MG TABLET is used to manage immune thrombocytopenia in patients aged 1-yearabove when other medicines (such as

revolade Revolade space ELTROMBOPAG Source, S100 HSD Public Body System, BLOOD AND BLOOD FORMING ORGANS > ANTIHEMORRHAGICS > VITAMIN K AND OTHER HEMOSTATICS Note

revolade Revolade is indicated in adult patients with chronic hepatitis C virus infection for the treatment of thrombocytopenia, where the degree of REVOLADE Page 2 2 Page 3 Your practical guide CONTENTS 4 Supporting your eltrombopag patients 6 What is eltrombopag? 8 Prescribing